Effects of L-Carnitine supplementation on levels of
inflammatory markers
The mean levels of inflammation markers before and after supplementation
on 7 days are shown in Table 3. A significant decline was observed in
serum IL-6 levels in the LC group (p<0.001), while IL-6 levels
significantly increased in the placebo group (P=0.001), and the mean
change between groups was statistically significant (P<0.001)
in which LC group showed both clinical and statistical significant
decline compared to placebo group. Likewise, in comparison to the
baseline, at post intervention, CRP significantly decreased in the LC
group though it did not change in the placebo group, and the difference
between groups was statistically significant (P=0.009).